Genpact and STADA, a manufacturer of consumer healthcare, generic and specialty pharma medicines, today announced the renewal of a multi-year partnership. The new chapter of innovation is aimed at further derisking, scaling, and simplifying STADA’s finance operations to drive competitive advantages.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on G: